{"count": 6, "results": [{"_id": "6792528", "pmid": 6792528, "title": "[The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)].", "journal": "MMW Munch Med Wochenschr", "authors": ["Bischoff K"], "date": "1981-09-04T00:00:00Z", "meta_date_publication": "1981 Sep 4", "meta_volume": "123", "meta_issue": "36", "meta_pages": "1337-40", "score": 50074.523, "text_hl": "[The effects of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on the exercise symptoms of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Bischoff K. [The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)]. MMW Munch Med Wochenschr. 1981 Sep 4;123(36):1337-40. PMID: 6792528", "BibTeX": "@article{6792528, title={[The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)].}, author={Bischoff K}, journal={MMW Munch Med Wochenschr}, volume={123}, number={36}, pages={1337-40}}"}}, {"_id": "710288", "pmid": 710288, "title": "[The hypertensive heart. VII. Effect of atenolol on the function, coronary haemodynamics and oxygen uptake of the left ventricle (author's transl)].", "journal": "Dtsch Med Wochenschr", "authors": ["Strauer BE"], "date": "1978-11-10T00:00:00Z", "doi": "10.1055/s-0028-1129343", "meta_date_publication": "1978 Nov 10", "meta_volume": "103", "meta_issue": "45", "meta_pages": "1785-9", "score": 50061.777, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ increased the coronary reserve of the left ventricle by about 21% in the five @SPECIES_9606 @@@patients@@@ in whom it was measured. ", "citations": {"NLM": "Strauer BE. [The hypertensive heart. VII. Effect of atenolol on the function, coronary haemodynamics and oxygen uptake of the left ventricle (author's transl)]. Dtsch Med Wochenschr. 1978 Nov 10;103(45):1785-9. PMID: 710288", "BibTeX": "@article{710288, title={[The hypertensive heart. VII. Effect of atenolol on the function, coronary haemodynamics and oxygen uptake of the left ventricle (author's transl)].}, author={Strauer BE}, journal={Dtsch Med Wochenschr}, volume={103}, number={45}, pages={1785-9}}"}}, {"_id": "10219461", "pmid": 10219461, "title": "Antianginal effects of ranolazine in various experimental models of angina.", "journal": "Arzneimittelforschung", "authors": ["Wang JX", "Maruyama K", "Murakami M", "Endo T", "Komatsu H", "Akahane M"], "date": "1999-03-01T00:00:00Z", "doi": "10.1055/s-0031-1300401", "meta_date_publication": "1999 Mar", "meta_volume": "49", "meta_issue": "3", "meta_pages": "193-9", "score": 50051.562, "text_hl": "In anesthetized @SPECIES_9615 @@@dogs@@@, intraduodenal administration of KEG-1295 (10, 30, or 50 mg/kg) or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (10 mg/kg) significantly attenuated the ST-T wave elevation induced by 2-min @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary ligation@@@ imposed during electrical heart pacing (200 beats/min). ", "citations": {"NLM": "Wang JX, Maruyama K, Murakami M, Endo T, Komatsu H, Akahane M. Antianginal effects of ranolazine in various experimental models of angina. Arzneimittelforschung. 1999 Mar;49(3):193-9. PMID: 10219461", "BibTeX": "@article{10219461, title={Antianginal effects of ranolazine in various experimental models of angina.}, author={Wang JX and Maruyama K and Murakami M and Endo T and Komatsu H and Akahane M}, journal={Arzneimittelforschung}, volume={49}, number={3}, pages={193-9}}"}}, {"_id": "1362612", "pmid": 1362612, "title": "[Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].", "journal": "Presse Med", "authors": ["Ménard J", "Chatellier G"], "date": "1992-11-07T00:00:00Z", "meta_date_publication": "1992 Nov 7", "meta_volume": "21", "meta_issue": "37", "meta_pages": "1762-7", "score": 50046.695, "text_hl": "The treatment, based on low doses of diuretic (@CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@ 12.5-25 mg daily) combined, when necessary, with a cardioselective beta-blocker (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 25 to 50 mg daily), significantly reduced the incidence of cerebrovascular and @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ events; the relative risk reduction for total mortality was not statistically significant. ", "citations": {"NLM": "Ménard J, Chatellier G. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments]. Presse Med. 1992 Nov 7;21(37):1762-7. PMID: 1362612", "BibTeX": "@article{1362612, title={[Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].}, author={Ménard J and Chatellier G}, journal={Presse Med}, volume={21}, number={37}, pages={1762-7}}"}}, {"_id": "16154017", "pmid": 16154017, "title": "Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).", "journal": "Lancet", "authors": ["Poulter NR", "Wedel H", "Dahlöf B", "Sever PS", "Beevers DG", "Caulfield M", "Kjeldsen SE", "Kristinsson A", "McInnes GT", "Mehlsen J", "Nieminen M", "O'Brien E", "Ostergren J", "Pocock S", "ASCOT Investigators"], "date": "2005-09-10T00:00:00Z", "doi": "10.1016/S0140-6736(05)67186-3", "meta_date_publication": "2005 Sep 10-16", "meta_volume": "366", "meta_issue": "9489", "meta_pages": "907-13", "score": 50042.71, "text_hl": "BACKGROUND: Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary and stroke@@@ events in individuals allocated an @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@-based combination drug regimen than in those allocated an @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-based combination drug regimen (HR 0.86 and 0.77, respectively). ", "citations": {"NLM": "Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S, ASCOT Investigators. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005 Sep 10-16;366(9489):907-13. PMID: 16154017", "BibTeX": "@article{16154017, title={Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).}, author={Poulter NR and Wedel H and Dahlöf B and Sever PS and Beevers DG and Caulfield M and Kjeldsen SE and Kristinsson A and McInnes GT and Mehlsen J and Nieminen M and O'Brien E and Ostergren J and Pocock S and ASCOT Investigators}, journal={Lancet}, volume={366}, number={9489}, pages={907-13}}"}}, {"_id": "2631476", "pmid": 2631476, "title": "[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].", "journal": "Z Kardiol", "authors": ["Rafflenbeul W", "Jost S", "Berger C", "Lichtlen P"], "date": "1989-01-01T00:00:00Z", "meta_date_publication": "1989", "meta_volume": "78 Suppl 5", "meta_issue": "", "meta_pages": "16-9", "score": 50039.793, "text_hl": "32 @SPECIES_9606 @@@patients@@@ in an early state of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary sclerosis@@@ were investigated in connection with diagnostic angiography. 8 @SPECIES_9606 @@@patients@@@ received 2 mg @CHEMICAL_Gallopamil @CHEMICAL_MESH:D005711 @@@gallopamil@@@ (G) and for every 12 @SPECIES_9606 @@@patients@@@ 0.1 mg/kg @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ (@CHEMICAL_Phosphorus @CHEMICAL_MESH:D010758 @@@P@@@), respectively, 0.12 mg/kg @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ (A). ", "citations": {"NLM": "Rafflenbeul W, Jost S, Berger C, Lichtlen P. [Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter]. Z Kardiol. 1989;78 Suppl 5():16-9. PMID: 2631476", "BibTeX": "@article{2631476, title={[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].}, author={Rafflenbeul W and Jost S and Berger C and Lichtlen P}, journal={Z Kardiol}, volume={78 Suppl 5}, pages={16-9}}"}}]}